Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

for
Pediatric ALL, Cardiac Defect
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 0 - 18

Code: NCT06529575

Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for
Esophageal Squamous Cell Carcinoma
Location: Morristown NJ, Hershey PA, Brooklyn NY, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase 3, Recruiting

Orphan Indications for CD19 Redirected Autologous T Cells

for
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALL,
Location: Philadelphia PA
Sponsor: Stephan Grupp MD PhD

Sex: All

Age: 0 - 29

Code: NCT04276870

Phase 2, Recruiting

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.

for
Invasive Mold Infections
Location: Philadelphia PA, New York NY, Baltimore MD, Hamilton,
Sponsor: Basilea Pharmaceutica

Sex: All

Age: 18+

Code: NCT06925321

Phase 3, Recruiting

CEUS Evaluation of Hydrocephalus in Neonates and Infants

for
Hydrocephalus in Infants, Hydrocephalus Acquired
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 1

Code: NCT06693752

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase 2, Recruiting

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

for
Idiopathic Inflammatory Myopathy, Dermatomyositis,
Location: Philadelphia PA, New York NY, The Bronx NY, Bethesda MD,
Sponsor: Cabaletta Bio

Sex: All

Age: 6 - 70+

Code: NCT06154252

Phase 2, Phase 3, Recruiting

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

for
Palmoplantar Pustulosis
Location: Philadelphia PA, Elmhurst NY, Hamilton, Markham,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT07013201

Phase 2, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Marlton NJ, New York NY, The Bronx NY, Cedarhurst NY,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase 3, Recruiting

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

for
Cystic Fibrosis
Location: Philadelphia PA, Baltimore MD, Rochester NY,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center

Sex: All

Age: 3 - 18

Code: NCT06654752

Recruiting

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

for
Congenital Disorders of Glycosylation
Location: Philadelphia PA, New York NY, Pittsburgh PA, Boston MA,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 0+

Code: NCT04199000

Recruiting

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

for
Sickle Cell Disease
Location: Philadelphia PA, New York NY, Providence RI, Boston MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 55

Code: NCT06546670

Phase 1, Phase 2, Recruiting

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

for
Familial Partial Lipodystrophy
Location: Philadelphia PA, Boston MA, Ann Arbour MI, Milwaukee WI,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 13+

Code: NCT06679270

Phase 3, Recruiting

Two Dose Levels of Privigen in Pediatric CIDP

for
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Location: Philadelphia PA, Flower Mound TX, Seattle WA
Sponsor: CSL Behring

Sex: All

Age: 2 - 17

Code: NCT03684018

Recruiting

Neuroblastoma Biology Study

for
Neuroblastoma
Location: Philadelphia PA, Boston MA, Toronto, Columbus OH,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 0 - 70+

Code: NCT01587300

Recruiting

A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

for
Hypothalamic Obesity,
Location: Philadelphia PA, New York NY, Boston MA, Chicago IL,
Sponsor: Rhythm Pharmaceuticals, Inc.

Sex: All

Age: 4+

Code: NCT06760546

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

for
Acute Treatment of Migraine
Location: Philadelphia PA, Port Jefferson Station NY,
Sponsor: Pfizer

Sex: All

Age: 6 - 11

Code: NCT06995729

Phase 1, Recruiting

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

for
Turner Syndrome
Location: Philadelphia PA, Washington DC, Chapel Hill NC,
Sponsor: University of Colorado, Denver

Sex: Female

Age: 0+

Code: NCT05052606

Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New Brunswick NJ, Newark DE, New York NY, New Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery

for
Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 1

Code: NCT05673499

Recruiting